Is the survival of melanoma patients receiving polyvalent melanoma cell vaccine linked to the human leukocyte antigen phenotype of patients?

doi:10.1200/JCO.1998.16.4.1430

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Is the survival of melanoma patients receiving polyvalent melanoma cell vaccine linked to the human leukocyte antigen phenotype of patients?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Apr 1998

Hoon D S, Okamoto T, Wang H J, Elashoff R, Nizze A J, Foshag L J, Gammon G, Morton D L

Abstract excerpt

PURPOSE: An allogeneic polyvalent melanoma cell vaccine (PMCV) has been shown to be efficacious in improving overall survival of patients with malignant melanoma in a phase II clinical setting. The PMCV consists of three allogeneic melanoma cell lines. The objectives of the study were to determin...

Topics

Adult
Cancer Vaccines
Female
Histocompatibility Antigens Class I
Histocompatibility Testing
Humans
Male
Melanoma
Middle Aged
Phenotype
Survival Analysis
Vaccines
Vaccines, Combined

Source

Open in PubMed

Identifiers

PMID: 9552048
DOI: 10.1200/JCO.1998.16.4.1430

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-9552048-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics